Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Millions |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Jun. 26, 2017 |
Sep. 30, 2016 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
| Stockholders' Equity, Reverse Stock Split | presented to reflect the 3.0-to-1.0 reverse stock split. | |||
| Stock Issued During Period, Shares, New Issues | 250,000 | |||
| Preferred Stock, Dividend Rate, Percentage | 2.50% | |||
| Fortress Biotech, Inc [Member] | ||||
| Research and Development in Process | $ 0.0 | $ 1.1 | ||
| X | ||||||||||
- Definition The percentage rate used to calculate dividend payments on preferred stock. No definition available.
|
| X | ||||||||||
- Definition The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|